Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Kyverna Therapeutics, Inc. (KYTX) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-42.08M |
|
-- |
|
-- |
|
$44.41M |
|
$-44.41M |
|
$2.33M |
|
$-42.08M |
|
$-42.08M |
|
$-42.08M |
|
$-42.08M |
|
$-42.08M |
|
$-42.08M |
|
$-44.41M |
|
$-43.90M |
|
43.23M |
|
43.23M |
|
$-0.97 |
|
$-0.97 |
|
| Balance Sheet Financials | |
$214.33M |
|
$2.16M |
|
$12.18M |
|
$226.51M |
|
$39.79M |
|
$0.03M |
|
$2.34M |
|
$42.13M |
|
$184.38M |
|
$184.38M |
|
$184.38M |
|
43.24M |
|
| Cash Flow Statement Financials | |
$-76.86M |
|
$34.74M |
|
$-1.06M |
|
$97.17M |
|
$53.99M |
|
$-43.18M |
|
$4.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.39 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-76.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.82% |
|
-22.82% |
|
-18.58% |
|
-22.82% |
|
$4.26 |
|
$-1.78 |
|
$-1.78 |
|